Dendritic cells

Cutting edge: B220+CCR9 dendritic cells are not plasmacytoid dendritic cells but are precursors of conventional dendritic cells Segura, E. et al. J. Immunol. 1 Jul 2009 (doi:10.4049/jimmunol.0901524)

A study published by Eugene Butcher and colleagues in Nature Immunology last year suggested that differential expression of CC-chemokine receptor 9 (CCR9) could distinguish functional subsets of plasmacytoid dendritic cells (pDCs). However, in this study, José Villadangos and colleagues show that CD11c+B220+ cells that lack CCR9 expression cannot be classified as pDCs. The CCR9 cells did not express some classical pDC markers but they did express markers of conventional DCs, and did not produce interferon-α after stimulation. The B220+CCR9 cells were also functionally comparable to conventional DCs in terms of their ability to present exogenous antigens on MHC class I and II molecules. B220+CCR9 cells differentiated into the two main populations of conventional splenic DCs after adoptive transfer in vivo. These results indicate that B220+CCR9 cells are not pDCs but precursors of conventional DCs.

T cell differentiation

Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12 Schmitt, N. et al. Immunity 11 Jul 2009 (doi:10.1016/j.immuni.2009.04.016)

This paper extends our knowledge of the developmental pathway of human T follicular helper (TFH) cells, which provide help for antibody-producing B cells in germinal centres by producing interleukin-21 (IL-21). The authors showed that IL-12 produced by activated dendritic cells (DCs) can induce naive CD4+ T cells to secrete IL-21 in vitro. IL-12 is a potent inducer of TH1 cells, and indeed most of the IL-21-producing cells also produced interferon-γ (IFNγ); however, there was also a small population of IFNγIL-21+ cells that lacked T-bet expression. Human CD4+ T cells primed in the presence of IL-12 could induce naive B cells to produce immunoglobulins. IL-12 could also induce memory CD4+ T cells to produce IL-21. This role for IL-12 in the induction of IL-21-producing TFH cells is not shared by mice, in which IL-6 and IL-21 have been shown to be important for TFH cell development.

Tumour immunology

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies Peggs, K. S. et al. J. Exp. Med. 6 Jul 2009 (doi:10.1084/jem.20082492)

Antibodies that block cytotoxic T lymphocyte antigen 4 (CTLA4) have been used to increase antitumour immune responses, but it is unclear whether effector T cells or regulatory T (TReg) cells are the target of this inhibition. The authors carried out suppression assays using combinations of effector and TReg cells from wild-type or transgenic mice that expressed human CTLA4. Blocking CTLA4 on wild-type effector T cells with an antibody that targets mouse CTLA4 resulted in increased baseline effector T cell proliferation, but blocking CTLA4 on TReg cells had a more modest effect; blocking both T cell subsets indicated a potential additive effect. Blocking CTLA4 on both effector and TReg cells in vivo also had the highest antitumour activity and mouse survival rates, indicating that targeting both T cell subsets would have the greatest benefit during cancer immunotherapy.